Sepsis is the most common cause of death in hospital ICUs today. It continues to threaten patient safety and is now the #1 cost of hospitalization in the U.S. Despite significant investments in screening and detection methods for sepsis, treating physicians still wait days for the diagnostic information needed to best cure underlying infections. These periods of uncertainty often define the patient’s fate.
With rising rates of antibiotic resistance, selecting effective therapy involves more than just identifying the infecting organism. Now physicians need to know how the infection will respond to different antibiotics — as quickly as possible.
We solve this problem. By cutting the wait time by days for antibiotic susceptibility results, a growing number of health system leaders are transforming sepsis management, providing patient-specific treatment for sepsis cases.
Faster sepsis treatment requires faster diagnostics.
The Accelerate Pheno™ system delivers phenotypic antibiotic susceptibility results along with organism identification directly from positive blood cultures — critical information to select the best drug, for the specific pathogen, at the MIC-driven dose ~ 40 hours faster than current methods used in most labs today.5
Hospitals are now dramatically shortening the time to get patients on the best antibiotic therapy while also freeing up time for laboratory technicians.
This earlier infection intelligence equips hospital teams to reduce adverse effects of antibiotic overuse — and gain ground against sepsis morbidity and mortality — by ensuring patients receive optimal, individualized sepsis treatment as quickly as possible.* Based on peer-reviewed publications comparing IVD-cleared methods through June 2019. Actual time to results may vary.
Septicemia is now the most expensive condition treated in your hospital1
- Every 3-4 seconds someone dies of sepsis
- Common infections your team regularly treats can now lead to severe sepsis2
- 1 out of every 5 severe sepsis cases are readmitted within 30 days3
- Sepsis hospitalizations account for a higher proportion of unplanned 30-day readmissions than those for heart attack, COPD, and pneumonia4
1 Torio and Moore. National Inpatient Hospital Costs (2016)
2 CDC. Data & Reports (2018)
3 Donnelly, J P, et al. Crit Care Med (2015)
4 Mayr, F B, et al. JAMA (2017)
5 Banerjee R, et al. Randomized trial evaluating clinical impact of RAPid IDentification and Susceptibility testing for Gram Negative bacteremia (RAPIDS-GN), Clin Infect Dis. 2020
View Outcomes Data